Siemens Healthineers AG (OTCMKTS:SMMNY) Short Interest Up 17.5% in September

Siemens Healthineers AG (OTCMKTS:SMMNYGet Free Report) was the target of a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 6,700 shares, an increase of 17.5% from the August 31st total of 5,700 shares. Based on an average trading volume of 69,500 shares, the short-interest ratio is presently 0.1 days.

Siemens Healthineers Price Performance

SMMNY stock opened at $29.99 on Monday. Siemens Healthineers has a 52-week low of $24.01 and a 52-week high of $31.73. The business has a fifty day moving average of $28.00 and a two-hundred day moving average of $28.65.

Siemens Healthineers (OTCMKTS:SMMNYGet Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.28 earnings per share (EPS) for the quarter. The company had revenue of $5.84 billion during the quarter.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on SMMNY. Sanford C. Bernstein raised shares of Siemens Healthineers to a “strong-buy” rating in a report on Wednesday, July 31st. UBS Group downgraded shares of Siemens Healthineers from a “strong-buy” rating to a “hold” rating in a report on Thursday.

View Our Latest Research Report on Siemens Healthineers

Siemens Healthineers Company Profile

(Get Free Report)

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.

Read More

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.